Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Recruiting · NCT06797401 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, metabolic disease | Recruiting | Phase 2 | 2026-09-10 | NCT06797401 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ribocure Pharmaceuticals AB | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akademiska Sjukhuset Uppsala | Uppsala | Sweden | 1 |
| AkardoMedSite | Stockholm | Sweden | 1 |
| Lunds Universitetssjukhus | Lund | Sweden | 1 |
| Ribocure Clinic/Ribocure Pharmaceuticals AB | Mölndal | Sweden | 1 |